Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salikh Murtazaliev

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cureus|September 14, 2020
Desmoplastic Trichoepithelioma: Histopathologic and Immunohistochemical Criteria for Differentiation of a Rare Benign Hair Follicle Tumor From Other Cutaneous Adnexal TumorsJawaria Rahman, Muhammad Tahir, Hassan Arekemase, et al.
Cureus|June 25, 2020
Coronavirus Disease 2019 (COVID-19) in Children: Vulnerable or Spared? A Systematic ReviewHajra Saleem, Jawaria Rahman, Nida Aslam, et al.
The Journal of Urology|February 5, 2026
Reply: Performance of <sup>99m</sup>Tc-Sestamibi Single-Photon Emission Computed Tomography/Computed Tomography for Characterizing Renal Masses: Combined Results From a Prospective Scan-and-Resect Trial and Clinical ExperienceSteven P Rowe, Salikh Murtazaliev, Hiten D Patel, et al.
The Journal of Urology|February 6, 2026
Reply by AuthorsSteven P Rowe, Salikh Murtazaliev, Hiten D Patel, et al.
Cureus|September 21, 2020
FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic ReviewNida Aslam, Hajra Saleem, Salikh Murtazaliev, et al.
PET Clinics|January 10, 2024
Positron Emission Tomography/Computed Tomography Transformation of Oncology: Multiple MyelomaSalikh Murtazaliev, Steven P Rowe, Sara Sheikhbahaei, et al.
Molecular Imaging and Biology|July 30, 2024
Imaging of Chromophobe Renal Cell Carcinoma with <sup>99m</sup>Tc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic ReclassificationSteven P Rowe, Salikh Murtazaliev, Jorge D Oldan, et al.
BJU International|September 23, 2024
The use of <sup>99m</sup>Tc-tetrofosmin in the characterisation of indeterminate renal masses: a pilot studyErgi Spiro, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Nuclear Medicine Communications|January 29, 2025
Lack of effect of renal function on uptake of 99m Tc-sestamibi in renal massesAlireza Amindarolzarbi, Kendall Satcowitz, Adham Khalil, et al.
The Journal of Urology|April 9, 2026
Reply by AuthorsSteven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cureus|September 14, 2020
Desmoplastic Trichoepithelioma: Histopathologic and Immunohistochemical Criteria for Differentiation of a Rare Benign Hair Follicle Tumor From Other Cutaneous Adnexal TumorsJawaria Rahman, Muhammad Tahir, Hassan Arekemase, et al.
Cureus|June 25, 2020
Coronavirus Disease 2019 (COVID-19) in Children: Vulnerable or Spared? A Systematic ReviewHajra Saleem, Jawaria Rahman, Nida Aslam, et al.
The Journal of Urology|February 5, 2026
Reply: Performance of <sup>99m</sup>Tc-Sestamibi Single-Photon Emission Computed Tomography/Computed Tomography for Characterizing Renal Masses: Combined Results From a Prospective Scan-and-Resect Trial and Clinical ExperienceSteven P Rowe, Salikh Murtazaliev, Hiten D Patel, et al.
The Journal of Urology|February 6, 2026
Reply by AuthorsSteven P Rowe, Salikh Murtazaliev, Hiten D Patel, et al.
Cureus|September 21, 2020
FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic ReviewNida Aslam, Hajra Saleem, Salikh Murtazaliev, et al.
PET Clinics|January 10, 2024
Positron Emission Tomography/Computed Tomography Transformation of Oncology: Multiple MyelomaSalikh Murtazaliev, Steven P Rowe, Sara Sheikhbahaei, et al.
Molecular Imaging and Biology|July 30, 2024
Imaging of Chromophobe Renal Cell Carcinoma with <sup>99m</sup>Tc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic ReclassificationSteven P Rowe, Salikh Murtazaliev, Jorge D Oldan, et al.
BJU International|September 23, 2024
The use of <sup>99m</sup>Tc-tetrofosmin in the characterisation of indeterminate renal masses: a pilot studyErgi Spiro, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Nuclear Medicine Communications|January 29, 2025
Lack of effect of renal function on uptake of 99m Tc-sestamibi in renal massesAlireza Amindarolzarbi, Kendall Satcowitz, Adham Khalil, et al.
The Journal of Urology|April 9, 2026
Reply by AuthorsSteven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Pageof 2